3QC4
PDK1 in complex with DFG-OUT inhibitor xxx
Summary for 3QC4
Entry DOI | 10.2210/pdb3qc4/pdb |
Related | 3PWY |
Descriptor | 3-phosphoinositide-dependent protein kinase 1, 1-(3,4-difluorobenzyl)-2-oxo-N-{(1R)-2-[(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)oxy]-1-phenylethyl}-1,2-dihydropyridine-3-carboxamide (3 entities in total) |
Functional Keywords | serine/threonine kinase, phosphorylation, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (human) |
Cellular location | Cytoplasm: O15530 |
Total number of polymer chains | 2 |
Total formula weight | 72478.83 |
Authors | Arndt, J.W. (deposition date: 2011-01-15, release date: 2011-04-20, Last modification date: 2024-10-16) |
Primary citation | Erlanson, D.A.,Arndt, J.W.,Cancilla, M.T.,Cao, K.,Elling, R.A.,English, N.,Friedman, J.,Hansen, S.K.,Hession, C.,Joseph, I.,Kumaravel, G.,Lee, W.C.,Lind, K.E.,McDowell, R.S.,Miatkowski, K.,Nguyen, C.,Nguyen, T.B.,Park, S.,Pathan, N.,Penny, D.M.,Romanowski, M.J.,Scott, D.,Silvian, L.,Simmons, R.L.,Tangonan, B.T.,Yang, W.,Sun, L. Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery. Bioorg.Med.Chem.Lett., 21:3078-3083, 2011 Cited by PubMed Abstract: We report the use of a fragment-based lead discovery method, Tethering with extenders, to discover a pyridinone fragment that binds in an adaptive site of the protein PDK1. With subsequent medicinal chemistry, this led to the discovery of a potent and highly selective inhibitor of PDK1, which binds in the 'DFG-out' conformation. PubMed: 21459573DOI: 10.1016/j.bmcl.2011.03.032 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.8 Å) |
Structure validation
Download full validation report